IRIDEX Corporation EPS Ratio 2011-2026 | IRIX

EPS is a measure used to assess the financial stability and profitability of a company. EPS (Earnings Per Share) represents the company's net income divided by the number of its outstanding shares. This measure allows investors and analysts to evaluate the return on investment in the company's stock and compare it to other companies in the industry.

The term earnings per share (EPS) represents the portion of a company's earnings, net of taxes and preferred stock dividends, that is allocated to each share of common stock. The figure can be calculated simply by dividing net income earned in a given reporting period (usually quarterly or annually) by the total number of shares outstanding during the same term. Because the number of shares outstanding can fluctuate, a weighted average is typically used.
Calculated as:
EPS = (Net Income - Dividends on Preffered Stock) / Average Outstanding shares^[1]

EPS can be calculated as a simple ratio of net income to shares, or in various variations, such as diluted EPS, which takes into account the potential issuance of new shares or convertible securities.

A high EPS ratio usually indicates that the company has good profitability and efficiency in utilizing its assets. However, other factors such as sales growth, debt burden, and the company's competitive position should also be considered.

EPS ratio is an important indicator for investors when making decisions to buy or sell a company's stock. It is also used by analysts to assess the financial condition of the company and its potential for growth and development.

Annual EPS Ratio IRIDEX Corporation

2026	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-0.26	-0.54	-0.59	-0.47	-0.46	-	-0.64	-1.05	-1.11	-1.15	1.01	-	0.24	0.16	0.29

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
1.01	-1.15	-0.352

Quarterly EPS Ratio IRIDEX Corporation

2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-0.09	-0.06	-0.1	-	-0.12	-0.16	-0.21	-	-0.11	-0.17	-0.13	-	-0.11	-0.14	-0.15	-	-0.14	0.09	-0.14	-	-0.12	-0.2	-0.12	-	-0.13	-0.18	-0.22	-	-0.26	-0.28	-0.31	-0.44	-0.27	-0.24	-0.16	-1.04	-0.07	-0.03	0.01	-	0.04	-0.07	0.02	-	0.05	0.03	0.05	-	0.05	0.05	0.1	-	-0.08	0.04	0.18	-	0.04	0.1	0.02

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
0.18	-1.04	-0.11

References

Khan, T. R., Islam, M. R., Choudhury, T. T., & Adnan, A. M. (2014). How earning per share (EPS) affects on share price and firm value.

EPS Ratio of other stocks in the Medical devices industry

Issuer	EPS Ratio	Price	% 24h	Market Cap	Country
AdaptHealth Corp. AHCO	-0.52	$ 12.86	-1.72 %	$ 1.74 B	USA
Allied Healthcare Products AHPI	-0.48	-	3.58 %	$ 2.21 M	USA
Apollo Endosurgery APEN	-0.98	-	-	$ 475 M	USA
Avinger AVGR	-23.3	-	-20.74 %	$ 369 K	USA
Electromed ELMD	0.89	$ 25.1	-0.59 %	$ 212 M	USA
Axonics Modulation Technologies AXNX	-1.28	-	-	$ 3.31 B	USA
EDAP TMS S.A. EDAP	-0.51	$ 3.36	1.46 %	$ 126 M	France
Aziyo Biologics AZYO	1.29	-	1.37 %	$ 20.5 M	USA
BIOLASE BIOL	-29.4	-	-13.19 %	$ 166 K	USA
BioSig Technologies BSGM	-9.65	-	37.08 %	$ 85.7 M	USA
Conformis CFMS	-6.99	-	-	$ 16.4 M	USA
ClearPoint Neuro CLPT	-0.9	$ 10.57	2.2 %	$ 299 M	USA
Cardiovascular Systems CSII	-0.94	-	0.15 %	$ 844 M	USA
Cytosorbents Corporation CTSO	-0.13	$ 0.63	-1.29 %	$ 39.2 M	USA
Helius Medical Technologies HSDT	-14.6	$ 2.0	1.01 %	$ 1.22 M	USA
Dynatronics Corporation DYNT	-1.43	-	14.99 %	$ 929 K	USA
Eargo EAR	-39.7	-	-	$ 10.2 M	USA
OrthoPediatrics Corp. KIDS	-1.69	$ 14.76	0.82 %	$ 346 M	USA
Butterfly Network BFLY	-0.34	$ 4.28	-13.01 %	$ 906 M	USA
Second Sight Medical Products EYES	-0.43	-	-0.97 %	$ 54.4 M	USA
LivaNova PLC LIVN	-4.45	$ 58.53	-0.66 %	$ 3.19 B	Britain
GBS GBS	-2	-	-0.57 %	$ 7.12 M	USA
Globus Medical GMED	3.98	$ 88.23	0.49 %	$ 11.9 B	USA
Delcath Systems DCTH	0.08	$ 10.25	0.39 %	$ 367 M	USA
Insulet Corporation PODD	3.51	$ 169.75	6.08 %	$ 11.9 B	USA
CONMED Corporation CNMD	1.52	$ 38.59	7.31 %	$ 1.2 B	USA
Inspire Medical Systems INSP	4.95	$ 53.41	-	$ 1.57 B	USA
Sintx Technologies SINT	-6.16	$ 2.0	0.5 %	$ 5.55 M	USA
Integer Holdings Corporation ITGR	2.96	$ 83.01	-0.79 %	$ 2.88 B	USA
Edwards Lifesciences Corporation EW	1.84	$ 80.96	-0.32 %	$ 47.3 B	USA
Invacare Corporation IVC	-0.54	-	-	$ 24.7 M	USA
Stryker Corporation SYK	2.21	$ 314.5	-0.2 %	$ 120 B	USA
Tactile Systems Technology TCMD	0.83	$ 22.53	0.13 %	$ 515 M	USA
TELA Bio TELA	-0.83	$ 0.84	-1.79 %	$ 39.4 M	USA
TransMedics Group TMDX	5.6	$ 98.83	0.26 %	$ 3.36 B	USA
Tandem Diabetes Care TNDM	-0.01	$ 18.77	3.33 %	$ 1.28 B	USA
LENSAR LNSR	-2.87	$ 5.38	-0.19 %	$ 64.3 M	USA
Pulmonx Corporation LUNG	-1.33	$ 1.25	4.17 %	$ 50.9 M	USA